LehmanSJSchlettCLBambergF. Assessment of coronary plaque progression in coronary computed tomography angiography using a semiquantitative score. JACC Cardiovasc Imaging. 2009;2(11):1262–1270.
2.
AyoubCYamYChenL. The prognostic value of percentage total plaque score adjusted to age: a potential marker of coronary vascular age. Angiology. 2016;67(10):916–926.
3.
HechtHS. Practice guidelines for electron beam tomography: a report of the Society of Atherosclerosis Imaging. Am J Cardiol. 2000;86(6):705–706, a709.
4.
BehrenbeckTRGerberTCMohlenkampS. Economic aspects of using electron beam computerized tomography. Z Kardiol. 2000;89(suppl 1):43–49.
5.
VliegenthartRMorrisPB. Computed tomography coronary artery calcium scoring: review of evidence base and cost-effectiveness in cardiovascular risk prediction. J Thorac Imaging. 2012;27(5):296–303.
6.
RattiCGrimaldiTLigabueG. Calcium score quantification using new techniques and its prognostic role in various subgroups of patients [in Italian]. Ital Heart J Suppl. 2003;4(6):477–480.
7.
SarwarAShawLJShapiroMD. Diagnostic and prognostic value of absence of coronary artery calcification. JACC Cardiovasc Imaging. 2009;2(6):675–688.
8.
SouteyrandGAmabileNCombaretN. Invasive management without stents in selected acute coronary syndrome patients with a large thrombus burden: a prospective study of optical coherence tomography guided treatment decisions. EuroIntervention. 2015;11(8):895–904.
9.
KajanderOAKoistinenLSEskolaM. Feasibility and repeatability of optical coherence tomography measurements of pre-stent thrombus burden in patients with STEMI treated with primary PCI. Eur Heart J Cardiovasc Imaging. 2015;16(1):96–107.
10.
VergalloRPapafaklisMIYonetsuT. Endothelial shear stress and coronary plaque characteristics in humans: combined frequency-domain optical coherence tomography and computational fluid dynamics study. Circ Cardiovasc Imaging. 2014;7(6):905–911.
11.
ShawEAllahwalaUKCockburnJA. The effect of coronary artery plaque composition, morphology and burden on absorb bioresorbable vascular scaffold expansion and eccentricity—a detailed analysis with optical coherence tomography. Int J Cardiol. 2015;184:230–236.
12.
FischerCHultenEBelurPSmithRVorosSVillinesTC. Coronary CT angiography versus intravascular ultrasound for estimation of coronary stenosis and atherosclerotic plaque burden: a meta-analysis. J Cardiovasc Comput Tomogr. 2013;7(4):256–266.
13.
Miszalski-JamkaTLicholaiSKarwatK. Computed tomography characteristics of coronary artery atherosclerosis in subjects with lower extremity peripheral artery disease and no cardiac symptoms. Pol Arch Med Wewn. 2013;123(12):657–663.
14.
BrugalettaSSabateM. Assessment of plaque composition by intravascular ultrasound and near-infrared spectroscopy: from PROSPECT I to PROSPECT II. Circ J. 2014;78(7):1531–1539.
15.
DohiTMaeharaAMorenoPR. The relationship among extent of lipid-rich plaque, lesion characteristics, and plaque progression/regression in patients with coronary artery disease: a serial near-infrared spectroscopy and intravascular ultrasound study. Eur Heart J Cardiovasc Imaging. 2015;16(1):81–87.
16.
StoneGWMaeharaAMullerJE. Plaque characterization to inform the prediction and prevention of periprocedural myocardial infarction during percutaneous coronary intervention: the CANARY Trial (Coronary Assessment by Near-infrared of Atherosclerotic Rupture-prone Yellow). JACC Cardiovasc Interv. 2015;8(7):927–936.
17.
MadssenEMoholdtTVidemVWisloffUHegbomKWisethR. Coronary atheroma regression and plaque characteristics assessed by grayscale and radiofrequency intravascular ultrasound after aerobic exercise. Am J Cardiol. 2014;114(10):1504–1511.
18.
MatsuoKUedaYTsujimotoM. Ruptured plaque and large plaque burden are risks of distal embolisation during percutaneous coronary intervention: evaluation by angioscopy and virtual histology intravascular ultrasound imaging. EuroIntervention. 2013;9(2):235–242.
19.
ChengJMGarcia-GarciaHMde BoerSP. In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the ATHEROREMO-IVUS study. Eur Heart J. 2014;35(10):639–647.
20.
GensiniGG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983;51(3):606.
21.
SerruysPWMoriceMCKappeteinAP. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961–972.
22.
ChanKPatelRSNewcombeP. Association between the chromosome 9p21 locus and angiographic coronary artery disease burden: a collaborative meta-analysis. J Am Coll Cardiol. 2013;61(9):957–970.
23.
KataokaYShaoMWolskiK. Myeloperoxidase levels predict accelerated progression of coronary atherosclerosis in diabetic patients: insights from intravascular ultrasound. Atherosclerosis. 2014;232(2):377–383.
24.
VorosSElashoffMRWingroveJABudoffMJThomasGSRosenbergS. A peripheral blood gene expression score is associated with atherosclerotic plaque burden and stenosis by cardiovascular CT-angiography: results from the PREDICT and COMPASS studies. Atherosclerosis. 2014;233(1):284–290.
25.
ChengJMOemrawsinghRMGarcia-GarciaHM. Relation of C-reactive protein to coronary plaque characteristics on grayscale, radiofrequency intravascular ultrasound, and cardiovascular outcome in patients with acute coronary syndrome or stable angina pectoris (from the ATHEROREMO-IVUS study). Am J Cardiol. 2014;114(10):1497–1503.
26.
CelikOOzturkDAkinF. Evaluation of lipoprotein-associated phosholipase A2 and plaque burden/composition in young adults. Coron Artery Dis. 2015;26(3):266–271.
27.
JoshiNVToorIShahAS. Systemic atherosclerotic inflammation following acute myocardial infarction: myocardial infarction begets myocardial infarction. J Am Heart Assoc. 2015;4(9):e001956.
28.
D’AscenzoFCerratoECalcagnoA. High prevalence at computed coronary tomography of non-calcified plaques in asymptomatic HIV patients treated with HAART: a meta-analysis. Atherosclerosis. 2015;240(1):197–204.
29.
MockelMMullerRSearleJ. Usefulness of beta2-microglobulin as a predictor of all-cause and nonculprit lesion-related cardiovascular events in acute coronary syndromes (from the PROSPECT study). Am J Cardiol. 2015;116(7):1034–1040.
30.
WentzelJJGijsenFJvan der GiessenR. Positive remodeling at 3 year follow up is associated with plaque-free coronary wall segment at baseline: a serial IVUS study. Atherosclerosis. 2014;236(1):82–90.
31.
DongLMintzGSWitzenbichlerB. Comparison of plaque characteristics in narrowings with ST-elevation myocardial infarction (STEMI), non-STEMI/unstable angina pectoris and stable coronary artery disease (from the ADAPT-DES IVUS substudy). Am J Cardiol. 2015;115(7):860–866.
32.
LiXVinkANiessenHW. Total burden of intraplaque hemorrhage in coronary arteries relates to the use of coumarin-type anticoagulants but not platelet aggregation inhibitors. Virchows Arch. 2014;465(6):723–729.
33.
InabaSMintzGSFarhatNZ. Impact of positive and negative lesion site remodeling on clinical outcomes: insights from PROSPECT. JACC Cardiovasc Imaging. 2014;7(1):70–78.
34.
CortiRBadimonJJ. Biologic aspects of vulnerable plaque. Curr Opin Cardiol. 2002;17(6):616–625.
35.
LibbyP. Molecular bases of the acute coronary syndromes. Circulation. 1995;91(11):2844–2850.
36.
PuriRNichollsSJEllisSGTuzcuEMKapadiaSR. High-risk coronary atheroma: the interplay between ischemia, plaque burden, and disease progression. J Am Coll Cardiol. 2014;63(12):1134–1140.
37.
NichollsSJKataokaY. Update in therapeutic approaches to plaque stabilization. Curr Atheroscler Rep. 2014;16(3):392.
38.
LeeCWHwangIParkCS. Differences in intravascular ultrasound and histological findings in culprit coronary plaques between ST-segment elevation myocardial infarction and stable angina. J Thromb Thrombolysis. 2014;37(4):443–449.
39.
TianJGuXSunY. Effect of statin therapy on the progression of coronary atherosclerosis. BMC Cardiovasc Disord. 2012;12:70.
40.
HouJXingLJiaH. Comparison of intensive versus moderate lipid-lowering therapy on fibrous cap and atheroma volume of coronary lipid-rich plaque using serial optical coherence tomography and intravascular ultrasound imaging. Am J Cardiol. 2016;117(5):800–806.
41.
BediUSinghMSinghPMolnarJKhoslaSAroraR. Effects of statins on progression of coronary artery disease as measured by intravascular ultrasound. J Clin Hypertens (Greenwich). 2011;13(7):492–496.
42.
RaberLTaniwakiMZauggS. Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study. Eur Heart J. 2015;36(8):490–500.
43.
KushnerPR. Can intensive statin therapy halt the progression of atherosclerosis? Recent evidence and potential implications for patient management. Prog Cardiovasc Nurs. 2007;22(4):207–213.
44.
LaRosaJC. Chemoprevention of coronary atherosclerosis: the role of lipid interventions. A position paper of the American Council on Science and Health. MedGenMed. 2002;4(1):12.
45.
NichollsSJSipahiISchoenhagenP. Intravascular ultrasound assessment of novel antiatherosclerotic therapies: rationale and design of the Acyl-CoA: cholesterol Acyltransferase Intravascular Atherosclerosis Treatment Evaluation (ACTIVATE) study. Am Heart J. 2006;152(1):67–74.
46.
de GraafMAJukemaJW. High coronary plaque load: a heavy burden. Eur Heart J. 2013;34(41):3168–3170.
47.
PuriRNissenSEShaoM. Coronary atheroma volume and cardiovascular events during maximally intensive statin therapy. Eur Heart J. 2013;34(41):3182–3190.
48.
WareWR. The mainstream hypothesis that LDL cholesterol drives atherosclerosis may have been falsified by non-invasive imaging of coronary artery plaque burden and progression. Med Hypotheses. 2009;73(4):596–600.
49.
KataokaYSt JohnJWolskiK. Atheroma progression in hyporesponders to statin therapy. Arterioscler Thromb Vasc Biol. 2015;35(4):990–995.
50.
WangXZhaoXLiLYaoHJiangYZhangJ. Effects of combination of ezetimibe and rosuvastatin on coronary artery plaque in patients with coronary heart disease. Heart Lung Circ. 2016;25(5):459–465.
